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Abstract
Background The emergence of the COVID-19 and its consequences has led to fears,
worries, and anxiety among individuals worldwide. The present study developed the Fear
of COVID-19 Scale (FCV-19S) to complement the clinical efforts in preventing the
spread and treating of COVID-19 cases.
Methods The sample comprised 717 Iranian participants. The items of the FCV-19S were
constructed based on extensive review of existing scales on fears, expert evaluations, and
participant interviews. Several psychometric tests were conducted to ascertain its reliabil-
ity and validity properties.
Results After panel review and corrected item-total correlation testing, seven items with
acceptable corrected item-total correlation (0.47 to 0.56) were retained and further
confirmed by significant and strong factor loadings (0.66 to 0.74). Also, other properties
evaluated using both classical test theory and Rasch model were satisfactory on the seven-
item scale. More specifically, reliability values such as internal consistency (α = .82) and
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test–retest reliability (ICC = .72) were acceptable. Concurrent validity was supported by
the Hospital Anxiety and Depression Scale (with depression, r = 0.425 and anxiety, r =
0.511) and the Perceived Vulnerability to Disease Scale (with perceived infectability, r =
0.483 and germ aversion, r = 0.459).
Conclusion The Fear of COVID-19 Scale, a seven-item scale, has robust psycho-
metric properties. It is reliable and valid in assessing fear of COVID-19 among
the general population and will also be useful in allaying COVID-19 fears among
individuals.
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One of the emergent global challenges in managing infectious diseases is dealing
with the novel coronavirus 2019 (COVID-19). The most common symptoms within
2–14 days include fever, fatigue, dry cough, myalgia, and dyspnea (Wang et al.
2020). As of March 1, 2020, the mortality rate was 3.6% in China and 1.5% outside
China (Baud et al. 2020), and as of March 14, 2020, 135 countries/territories had
confirmed cases (World Health Organization 2020). With the extremely high infec-
tion rate and relatively high mortality, individuals naturally began worrying about
the COVID-19. Indeed, fear of contacting individuals who are possibly infected by
COVID-19 has been reported (Lin 2020). Unfortunately, fear may amplify the
damage of the disease itself. The emergence of the COVID-19 (Guan et al. 2020;
Huang et al. 2020) and its pandemic nature has exacerbated fears worldwide leading
to stigma in some cases (Centers for Disease Control and Prevention 2020a, b; Lin
2020). One characteristic nature of infectious disease compared with other condi-
tions is fear. Fear is directly associated with its transmission rate and medium
(rapidly and invisibly) as well as its morbidity and mortality. This further leads to
other psychosocial challenges including stigmatization, discrimination, and loss
(Pappas et al. 2009). With the high levels of fear, individuals may not think clearly
and rationally when reacting to COVID-19.
However, current treatment on COVID-19 worldwide has mainly focused on
infection control, effective vaccine, and treatment cure rate (Dong et al. 2020; Wang
et al. 2020). The psychosocial aspect has yet to be thoroughly considered. Neverthe-
less, as countries worldwide have to work on reducing the transmission rate of
COVID-19, they should also work on individual fears to achieve the holistic goal
of having a society free of COVID-19. One of the reasons that current treatment on
COVID-19 pays little attention to the fear of COVID-19 is the lack of an appropriate
psychometric instrument. Therefore, developing a brief and valid instrument to capture
an individual’s fear of COVID-19 is both timely and important. With the information
on how an individual fears COVID-19, healthcare providers can further design
appropriate programs to take care of the fear. Therefore, this study developed and
validated a scale assessing the fear of coronavirus—the Fear of COVID-19 Scale
(FCV-19S) (see “Appendix” section)—using two types of psychometric testing: clas-
sical test theory (CTT) analysis and Rasch analysis. Consequently, the FCV-19S will
be useful in providing valuable information on fear of COVID-19 so as to facilitate
public health initiatives on allaying public’s fears.
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Methods
Development of the Scale
Several steps were taken to develop the Fear of COVID-19 Scale (McCoach et al. 2013). First, an
extensive literature review was conducted to assess all general scales on fear. Thirty measures on
fear were identified that assess fear on different populations and diseases (available on request
from the corresponding authors). Relevant and possible items were pooled by two researchers
(i.e., the third and last authors). After removing those itemswith similar content or expressions, 28
items were retained for further evaluation. Second, an expert panel (comprising a psychologist,
virologist, health psychologist, psychiatrist, general physician, and nurse) evaluated the 28 items,
and 11 items were deleted based on the suggestion from the expert panel. Third, the retained 17
items were sent out to a different expert panel (comprising a health education specialist,
pulmonologist, social psychologist, and sociologist in Iran) to review. Seven items were further
omitted based on the comments from the second expert panel. Finally, the 10-item scale was
piloted on 46 individuals (26 males and 20 females, mean age 39.63 years, number of years in
education = 9.38 years) to obtain initial assessment of the scale. A four-point Likert scale was used
to test whether the individuals understand the item descriptions. The results showed that all
respondents fully understood the item descriptions (mean 3.81, SD = 1.04). Additionally, an
individual telephone-based cognitive interview was implemented on the same pilot participants
to explore their thoughts about each scale item and their responses. No further changes were made
because the pilot participants indicated no changes were needed.
Participants and Procedure
The target population was the general Iranian population. Inclusion criteria were being (i) an
Iranian, (ii) aged 18 years or older, and (iii) being able to understand spoken Persian or Farsi.
Participants were recruited from online advertisements, e-mail campaigns, blogs, social media,
and SMS campaigns. All procedures conducted were approved by the Ethics Committee of
Qazvin University of Medical Sciences (IR.QUMS.REC.1398.375). Informed consent was
obtained electronically before data were collected from the participants.
Measures
Demographic Information
A background information sheet consisting of age, educational year, gender, and whether they
were a current smoker was used to obtain demographic information about the participants.
Hospital Anxiety and Depression Scale
The Persian version of Hospital Anxiety and Depression Scale (HADS) was used to assess the
anxiety and depression levels of participants. The HADS is a 14-item scale in which items are
answered in a four-point response format with a total score ranging from 0 to 21 for each of the
subscales (anxiety and depression with seven items each). Example items include “I have lost
interest in my appearance” (depression) and “Worrying thoughts go through my mind”
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(anxiety). A higher score is indicative of severe anxiety or depression. The scale has acceptable
reliability (Cronbach’s α of 0.78 and 0.86 for the HADS anxiety and depression respectively)
and a satisfactory validity (Montazeri et al. 2003).
Perceived Vulnerability to Disease Scale
The Persian version of the 15-item Perceived Vulnerability to Disease Scale (PVDS) was used
to assess participant’s perceived vulnerability to infectious disease specifically perceived
infectability (seven-item subscale) and germ aversion (eight-item subscale). Participants re-
spond to each item on a seven-point scale (from “strongly disagree” to “strongly agree”) with
approximately half of the items reverse-scored (Ahmadzadeh et al. 2013; Duncan et al. 2009).
Example items include “In general, I am very susceptible to colds, flu and other infectious
diseases” (perceived infectability) and “I prefer to wash my hands pretty soon after shaking
someone’s hand” (germ aversion). A higher score indicates a severe form of perceived
infectability, germ aversion, or perceived vulnerability to disease (as a whole). It has a
Cronbach’s α of 0.70, 0.72, and 0.70 for perceived infectability, germ aversion, and total
PVDS score respectively (Ahmadzadeh et al. 2013).
Data Analysis
Descriptive statistics were used to understand participants’ characteristics. Analyses on psy-
chometric properties included CTT analysis and Rasch model analysis. CTT analysis included
internal consistency, test-retest reliability, corrected item-total correlation, average variance
extracted (AVE), composite reliability, standard error of measurement, concurrent validity, and
exploratory factor analysis (EFA). Rasch model analysis included infit and outfit mean square
(MnSq) for each item, item and person separation reliability, and item and person separation
index. Also, differential item functioning (DIF) based on Rasch analysis was used to test the
measurement invariance across gender and age (Wu et al. 2017). All the descriptive and CTT
analyses were conducted using IBM SPSS 23.0 (IBM Corp., Armonk, NY). Also, the Rasch
model analyses were conducted using WINSTEPS 3.75.0.
Results
The mean age of the participants (n = 717) was 31.25 years (SD ± 12.68), and the participants
had, on average, 8.9 years of education (SD ± 4.1). More than half of the participants were
males (n = 416; 58%), and nearly one-fifth of the participants were current smokers (n = 139;
19.4%). According to the corrected inter-item correlation, three items with low corrected item-
total correlations were deleted (i.e., Item 3, − 0.06; Item 4, − 0.03; Item 5 − 0.05). The
remaining seven items in the scale all had acceptable corrected item-total correlation (0.47
to 0.56) and were used for following psychometric testing (Table 1).
All factor loadings from the retained seven items were significant and strong (0.66 to 0.74).
Their properties tested using Rasch analysis were satisfactory: infit MnSq values were between
0.80 and 1.26; outfit MnSq values were between 0.84 and 1.25. No substantial DIF was found
across gender and age (Table 2). Table 3 demonstrates that the seven-item scale had robust
psychometric properties in the scale level. From CTT analysis, the internal consistency was
good (α = .82), composite reliability (0.88) and AVE (0.51) were acceptable, and standard
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error of measurement was low (1.89). From Rasch analysis, item separation reliability (0.99),
item separation index (11.45), person separation reliability (0.77), and the person separation
index (2.82) were all satisfactory (Table 3).
Concurrent validity was supported by the HADS and PVDS as indicated by the significant
correlations (both p < 0.001). There were significant positive correlations between fear of
Table 1 Descriptive statistics and item-total correlation of the Fear of COVID-19 Scale (n = 717)
Item number Mean (SD) Corrected
item-total
correlation
Skewness Kurtosis Missing
data (%)
Floor
effect
(%)
Ceiling
effect
(%)
Item
exclusion
or
retention
Item 1. I am most
afraid of
coronavirus-19.
3.48 (1.14) 0.47 − 0.34 − 0.61 6.69 5.7 22.2 Retained
Item 2. It makes me
uncomfortable to
think about
coronavirus-19.
4.01 (0.84) 0.56 − 0.58 − 0.12 3.21 4.9 30.1 Retained
Item 3. I worry a lot
about
coronavirus-19.
3.43 (1.23) − 0.06 − 2.41 − 1.91 5.16 7.3 21.3 Excluded
Item 4.
Coronavirus-19 is
almost always ter-
minal
2.62 (1.16) − 0.03 0.24 − 2.12 9.34 18.4 3.8 Excluded
Item 5.
Coronavirus-19 is
an unpredictable
disease
3.91 (0.96) − 0.05 − 1.66 − 1.07 10.32 7.1 30.5 Excluded
Item 6. My hands
become clammy
when I think about
coronavirus-19
3.76 (0.88) 0.51 − 0.42 0.12 3.21 0.7 47.6 Retained
Item 7. I am afraid of
losing my life
because of
coronavirus-19
4.24 (0.90) 0.54 −1.18 0.98 3.07 0.4 34.3 Retained
Item 8.When watching
news and stories
about
coronavirus-19 on
social media, I be-
come nervous or
anxious.
3.53 (1.07) 0.51 − 0.36 − 0.47 2.51 1.4 20.5 Retained
Item 9. I cannot sleep
because I’m
worrying about
getting
coronavirus-19
4.11 (0.81) 0.48 − 0.79 0.56 5.43 3.9 20.8 Retained
Item 10. My heart
races or palpitates
when I think about
getting
coronavirus-19
4.26 (0.75) 0.53 − 0.91 0.78 5.86 2.5 42.1 Retained
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COVID-19 and (i) depression (r = 0.425, p < 0.001), (ii) anxiety (r = 0.511, p < 0.001), (iii)
perceived infectability (r = 0.483, p < 0.001), and (iv) germ aversion (r = 0.459, p < 0.001).
Discussion
The present study presented the development of a new scale, the Fear of COVID-19 Scale
(FC-19S). Findings demonstrated that the FCV-19S has a stable unidimensional structure with
robust psychometric properties. Initial psychometric results indicated that the FCV-19S had
good properties from different types of testing (i.e., CTT and Rasch analysis). Moreover, the
overall score of the summed-up items scores can indicate the severity of the fear of COVID-19.
Table 2 Psychometric properties of the Fear of COVID-19 Scale at the item level (n = 717)
Item number Factor
loading*
h2 Infit
MnSq
Outfit
MnSq
Difficulty DIF
contrast
across
gendercd
DIF
contrast
across
agece
Item 1. I am most afraid of
coronavirus-19.
0.66 0.38 1.26 1.25 0.98 − 0.10 − 0.05
Item 2. It makes me uncomfortable to
think about coronavirus-19.
0.74 0.55 0.80 0.84 − 0.17 − 0.33 − 0.22
Item 6. My hands become clammy when I
think about coronavirus-19.
0.71 0.51 0.81 0.85 0.39 − 0.29 0.25
Item 7. I am afraid of losing my life
because of coronavirus-19.
0.74 0.55 1.11 1.0 −0.77 0.29 0.21
Item 8. When watching news and stories
about coronavirus-19 on social media, I
become nervous or anxious.
0.71 0.50 1.01 1.0 0.85 0.48 0.30
Item 9. I cannot sleep because I’m
worrying about getting coronavirus-19.
0.71 0.50 0.90 0.94 − 0.43 − 0.24 − 0.31
Item 10. My heart races or palpitates when
I think about getting coronavirus-19.
0.73 0.54 0.81 0.91 − 0.83 0.21 − 0.23
MnSq mean square error, DIF differential item functioning
*Extraction method: Oblimin rotation with Kaiser normalization. h2 = communalities
c DIF contrast > 0.5 indicates substantial DIF
d DIF contrast across gender = difficulty for males-difficulty for females
e DIF contrast across age groups = Difficulty for younger (i.e., ≤ 31.25 years) - Difficulty for older (i.e., >
31.25 years) patients
Table 3 Psychometric properties of the Fear of COVID-19 Scale at the scale level (n = 717)
Psychometric testing Value Suggested cutoff
Composite reliability 0.88 > 0.7
Average variance extracted 0.51 > 0.5
Internal consistency (Cronbach’s α) 0.82 > 0.7
Standard error of measurement 1.89 The smaller the better
Item separation reliability from Rasch 0.99 > 0.7
Item separation index from Rasch 11.45 > 2
Person separation reliability from Rasch 0.77 > 0.7
Person separation index from Rasch 2.82 > 2
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More specifically, the higher the score on the FCV-19S, the higher the scores on the HADS
and the PVDS were. Therefore, higher overall scores on the FCV-19S indicate more severe
fear of COVID-19. Also, gender and age appeared not to affect the response pattern of the fear
on the FCV-19S. Therefore, it can be concluded that the FCV-19S can be relied upon to assess
and deal with the psychological issues emanating from COVID-19 among males and females
as well as individuals of all ages.
Other studies have shown that negative effects of psychological reactions such as hypo-
chondriasis and anxiety affect individuals’ health and well being during times of infectious
epidemic crisis (Duncan et al. 2009; Pappas et al. 2009; Ropeik 2004). The FCV-19S could
also help allay the fears of the public on COVID-19 and subsequently help in reducing the
stigma, anxiety, and stress attached to it (Centers for Disease Control and Prevention 2020a, b).
The concurrent validity, ascertained using the HADS and PVDS, indicates that the FCV-19S is
a valid tool for assessing fear of COVID-19. Also, the FCV-19S significantly correlated with
depression, anxiety (on the HADS), perceived infectability, and germ aversion (on the PVDS)
which suggests that individuals with severe fear of COVID-19 may have these comorbid
disorders.
The present study has some limitations. First, the studied participants were from the general
Iranian population and no formal diagnoses on mood disorders were obtained (e.g., anxiety).
Therefore, the sensitivity and specificity of the scale cannot be examined. Second, although
fear is subjective and has shortcomings when trying to assess it objectively, the nature of the
self-report cannot exclude the possibility that respondents provided responses affected by
social desirability factors. Third, convenience sampling weakens the generalizability of the
findings in the present study. Finally, the single-factor structure of the scale was based on EFA
and Rasch analysis; consequently, further verification, such as using confirmatory factor
analysis, on its factor structure is needed.
In conclusion, this study demonstrated that the Fear of COVID-19 Scale is a seven-item
unidimensional scale with robust psychometric properties. Moreover, total scores on the FCV-
19S are comparable across both genders and all ages which suggest that it is a good
psychometric instrument to be used in assessing and allaying fears of COVID-19 among
individuals.
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Appendix
Fear of Coronavirus-19 Scale
1. I am most afraid of coronavirus-19.
2. It makes me uncomfortable to think about coronavirus-19.
3. My hands become clammy when I think about coronavirus-19.
4. I am afraid of losing my life because of coronavirus-19.
5. When watching news and stories about coronavirus-19 on social media, I become nervous
or anxious.
6. I cannot sleep because I’m worrying about getting coronavirus-19.
7. My heart races or palpitates when I think about getting coronavirus-19.
The participants indicate their level of agreement with the statements using a five-item Likert-
type scale. Answers included “strongly disagree,” “disagree,” “neither agree nor disagree,”
“agree,” and “strongly agree”. The minimum score possible for each question is 1, and the
maximum is 5. A total score is calculated by adding up each item score (ranging from 7 to 35).
The higher the score, the greater the fear of cororonavirus-19.
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